Search

everythinglearnresearchcommunity

for

Search:↓

Patients with certain FoxN1 gene mutations have severe immune issues but normal skin and hair.

Alopecia areata patients have a higher risk of other immune-related diseases.

Hair follicle-derived melanocyte transplant could effectively treat vitiligo by restoring skin color.

Rehabilitation improved patients' mobility but did not reduce 30-day hospital readmission rates after stem cell transplants.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

The document doesn't provide a clear conclusion or detailed findings about the impact of certain cells on cancer treatment.

Autoimmune reactions may cause both alopecia areata and HAM.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Contact immunotherapy can improve hair regrowth in alopecia areata patients.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Syphilis can cause hair loss and skin changes in HIV-positive patients, and proper treatment can resolve these symptoms.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Transgender patients face unique skin issues due to hormone treatments and surgeries.

A combination of oral cyclosporin and PUVA treatment worked well for a severe skin condition called generalized pustular psoriasis.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

A young woman with lupus developed tuberculosis due to weakened immunity from her medication, showing the need for better TB screening in such patients.

Use steroid creams without parabens and educate on hair transplant techniques to improve cosmetic surgery outcomes.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

The document could not be processed to provide a conclusion.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Intralesional cidofovir may be a viable alternative treatment for SCC.

A new mouse model helps understand and find treatments for alopecia areata.

Patients treated with long-term intralesional corticosteroids for alopecia areata should be monitored for bone density changes and advised on osteoporosis prevention.

Platelet-rich plasma helps treat hair loss, and better screening improves transfusion safety.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.